Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Name: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C
Published: 2016
License: Public Domain

AbbVie · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

observational-study

chronic hepatitis c, ombitasvir/paritaprevir/ritonavir ± dasabuvir, sustained virological response, observational study, chronic hepatitis c genotype 1, chronic hepatitis c genotype 4, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Related documents